Revenue: The sum of all revenue fields included for a company's operating activities.
Endonovo Therapeutics, Inc. (ENDV) had Revenue of $0.01M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$0.01M |
$-1.60M |
|
$0.00M |
|
$0.00M |
|
$0.79M |
|
$-0.79M |
|
$-0.82M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-1.60M |
|
$-0.79M |
|
$-0.60M |
|
276.36M |
|
1.35B |
|
$0.00 |
|
$0.02 |
|
| Balance Sheet Financials | |
$0.02M |
|
-- |
|
$0.62M |
|
$0.64M |
|
$24.67M |
|
-- |
|
$0.08M |
|
$24.75M |
|
$-24.11M |
|
$-24.73M |
|
$-24.11M |
|
318.75M |
|
| Cash Flow Statement Financials | |
$0.12M |
|
-- |
|
$-0.12M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.29 |
|
49.57% |
|
-13140.23% |
|
-13140.23% |
|
-- |
|
-26803.73% |
|
-26803.73% |
|
$0.12M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
6.65% |
|
6.48% |
|
-251.28% |
|
6.65% |
|
$-0.08 |
|
$0.00 |
|
$0.00 |
|